NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.

The announcement by the US appliance giant comes at a time when its India business is delivering strong performance. The company reported a 40.13% rise in its consolidated net profit to Rs 53.53 crore ...

Premier Cement Mills PLC reported a profit of Tk 2.42 crore in the second quarter of the fiscal year 2024-25, marking an 89 ...

Whirlpool of India hit the lower circuit of 20% at Rs 1262.15 after the company's parent, Whirlpool Corporation, announced its intention to sell 20% stake in the company by mid to late 2025 by way of ...

Billings reached 50° for the first time in January 2025. We might be able to do that again on Thursday and Saturday, but there are changes beyond that.

Raymond James analyst S. Hansen now anticipates that the company will post earnings per share of $4.21 for […] ...

In total, 205 rail construction projects broke ground in 2024, with a combined capital investment of almost $390bn ...

Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...

Microsoft shared details on the company's financial results for Q2 FY25 on Wednesday, revealing that gaming revenue was down ...

We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...

Q2 2025 Earnings Conference Call January 29, 2025 5:30 PM ETCompany ParticipantsBrett Iversen - Vice President ...

President Trump on Monday fired all three Democrats on the Privacy and Civil Liberties Oversight Board (PCLOB), bringing much ...